AtaCor Medical Announces First Patient Treated Globally in its ALARION-EV Pivotal Trial
Study will evaluate AtaCor's investigational Atala™ lead in conjunction with Abbott's investigational EV-ICD pulse generator Study will evaluate a novel parasternal extravascular ICD approach for the treatment of life-threatening ventricular tachyarrhythmias SAN CLEMENTE, Calif., July 7,...
Study will evaluate AtaCor's investigational Atala™ lead in conjunction with Abbott's investigational EV-ICD pulse generator Study will evaluate a novel parasternal extravascular ICD approach for the treatment of life-threatening ventricular tachyarrhythmias SAN CLEMENTE, Calif., July 7,...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.